#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

byKathleen Lau

May 27, 2022

in StudyGraphics

Reading Time: 1 min read

Medical cannabis provides little improvement to sleep in chronic pain patients

RelatedReports

StudyGraphics

#VisualAbstract: Cutaneous immune-related adverse events were associated with increased survival in patients treated with immune checkpoint inhibitors

January 21, 2022

StudyGraphics

#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma

December 18, 2021

StudyGraphics

#VisualAbstract Assessing early tumour response and immune-related adverse events when undergoing combination nivolumab and ipilimumab therapy for advanced melanoma

November 18, 2021

StudyGraphics

#VisualAbstract: Sonelokimab showed significant clinical benefit over placebo in patients with plaque psoriasis

May 12, 2021

Unenhanced magnetic resonance imaging highly sensitive and specific for acute appendicitis

2 Minute Medicine Rewind May 30, 2022

Shift workers may have increased sleep disruption and use of sleep medication

Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source

New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

#VisualAbstract: Cutaneous immune-related adverse events were associated with increased survival in patients treated with immune checkpoint inhibitors

#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma

#VisualAbstract Assessing early tumour response and immune-related adverse events when undergoing combination nivolumab and ipilimumab therapy for advanced melanoma

Medical cannabis provides little improvement to sleep in chronic pain patients

2 Minute Medicine Rewind May 30, 2022

RelatedReports

#VisualAbstract: Cutaneous immune-related adverse events were associated with increased survival in patients treated with immune checkpoint inhibitors

#VisualAbstract An ixazomib-based regimen may be a better-tolerated approach in elderly patients with newly diagnosed multiple myeloma

#VisualAbstract Assessing early tumour response and immune-related adverse events when undergoing combination nivolumab and ipilimumab therapy for advanced melanoma

#VisualAbstract: Sonelokimab showed significant clinical benefit over placebo in patients with plaque psoriasis

2 Minute Medicine Rewind May 30, 2022

Shift workers may have increased sleep disruption and use of sleep medication

New-onset atrial fibrillation following hospitalization for pneumonia associated with increased thromboembolic risk

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports

#VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis

RELATED REPORTS

Medical cannabis provides little improvement to sleep in chronic pain patients

2 Minute Medicine Rewind May 30, 2022

RelatedReports

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2MM+ Premium Access

Recent Reports